141 related articles for article (PubMed ID: 34936855)
21. Persistent negative symptoms in young people at clinical high risk of psychosis treated with an Italian early intervention program: a longitudinal study.
Ricci C; Leuci E; Quattrone E; Palmisano D; Pellegrini P; Menchetti M; Pupo S; Pelizza L
Eur Arch Psychiatry Clin Neurosci; 2024 Apr; ():. PubMed ID: 38668766
[TBL] [Abstract][Full Text] [Related]
22. The course of negative symptoms in first-episode schizophrenia and its predictors: A prospective two-year follow-up study.
Mezquida G; Cabrera B; Bioque M; Amoretti S; Lobo A; González-Pinto A; Espliego A; Corripio I; Vieta E; Castro-Fornieles J; Bergé D; Escartí MJ; Ibañez Á; Penadés R; Sánchez-Torres AM; Bernardo M;
Schizophr Res; 2017 Nov; 189():84-90. PubMed ID: 28185786
[TBL] [Abstract][Full Text] [Related]
23. Identifying risk factors for predominant negative symptoms from early stages in schizophrenia: A longitudinal and sex-specific study in first-episode schizophrenia patients.
Mezquida G; Amoretti S; Bioque M; García-Rizo C; Sánchez-Torres AM; Pina-Camacho L; Lopez-Pena P; Mané A; Rodriguez-Jimenez R; Corripio I; Sarró S; Ibañez A; Usall J; García-Portilla MP; Vieta E; Mas S; Cuesta MJ; Parellada M; González-Pinto A; Berrocoso E; Bernardo M;
Span J Psychiatry Ment Health; 2023; 16(3):159-168. PubMed ID: 37716849
[TBL] [Abstract][Full Text] [Related]
24. Duration of untreated psychosis predicts treatment outcome in an early psychosis program.
Black K; Peters L; Rui Q; Milliken H; Whitehorn D; Kopala LC
Schizophr Res; 2001 Mar; 47(2-3):215-22. PubMed ID: 11278138
[TBL] [Abstract][Full Text] [Related]
25. Identifying persistent negative symptoms in first episode psychosis.
Hovington CL; Bodnar M; Joober R; Malla AK; Lepage M
BMC Psychiatry; 2012 Dec; 12():224. PubMed ID: 23217020
[TBL] [Abstract][Full Text] [Related]
26. Negative symptom subgroups have different effects on the clinical course of schizophrenia after the first episode: a 24-month follow up study.
Ergül C; Üçok A
Eur Psychiatry; 2015 Jan; 30(1):14-9. PubMed ID: 25174272
[TBL] [Abstract][Full Text] [Related]
27. Gender differences of neurocognitive functioning in patients with first-episode schizophrenia in China.
Pu C; Qiu Y; Zhou T; Yang F; Lu Z; Wang C; Deng H; Zhao J; Shi C; Yu X
Compr Psychiatry; 2019 Nov; 95():152132. PubMed ID: 31669790
[TBL] [Abstract][Full Text] [Related]
28. Differential impacts of duration of untreated psychosis (DUP) on cognitive function in first-episode schizophrenia according to mode of onset.
Ito S; Nemoto T; Tsujino N; Ohmuro N; Matsumoto K; Matsuoka H; Tanaka K; Nishiyama S; Suzuki M; Kinoshita H; Ozawa H; Fujita H; Shimodera S; Kishimoto T; Matsumoto K; Hasegawa T; Mizuno M
Eur Psychiatry; 2015 Nov; 30(8):995-1001. PubMed ID: 26497470
[TBL] [Abstract][Full Text] [Related]
29. The EPPIC follow-up study of first-episode psychosis: longer-term clinical and functional outcome 7 years after index admission.
Henry LP; Amminger GP; Harris MG; Yuen HP; Harrigan SM; Prosser AL; Schwartz OS; Farrelly SE; Herrman H; Jackson HJ; McGorry PD
J Clin Psychiatry; 2010 Jun; 71(6):716-28. PubMed ID: 20573330
[TBL] [Abstract][Full Text] [Related]
30. Duration of active psychosis and first-episode psychosis negative symptoms.
Lyne J; Joober R; Schmitz N; Lepage M; Malla A
Early Interv Psychiatry; 2017 Feb; 11(1):63-71. PubMed ID: 25582878
[TBL] [Abstract][Full Text] [Related]
31. Persistent negative symptoms in individuals at Ultra High Risk for psychosis.
Yung AR; Nelson B; McGorry PD; Wood SJ; Lin A
Schizophr Res; 2019 Apr; 206():355-361. PubMed ID: 30482643
[TBL] [Abstract][Full Text] [Related]
32. Depressive Features in Individuals with First Episode Psychosis: Psychopathological and Treatment Considerations from A 2-Year Follow-Up Study.
Pelizza L; Leuci E; Quattrone E; Azzali S; Paulillo G; Pupo S; Pellegrini P
Clin Neuropsychiatry; 2023 Feb; 20(1):39-47. PubMed ID: 36936626
[TBL] [Abstract][Full Text] [Related]
33. Individual psychotherapy can reduce suicidal ideation in first episode psychosis: Further findings from the 2-year follow-up of the 'Parma Early Psychosis' programme.
Pelizza L; Maestri D; Leuci E; Quattrone E; Azzali S; Paulillo G; Pellegrini P
Clin Psychol Psychother; 2022 May; 29(3):982-989. PubMed ID: 34704336
[TBL] [Abstract][Full Text] [Related]
34. Persistent negative symptoms in youth at clinical high risk for psychosis: A longitudinal study.
Devoe DJ; Lu L; Cannon TD; Cadenhead KS; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Woods SW; Walker EF; Mathalon DH; Bearden CE; Addington J
Schizophr Res; 2021 Jan; 227():28-37. PubMed ID: 32362460
[TBL] [Abstract][Full Text] [Related]
35. Quality of life and its predictors in first-episode schizophrenia and individuals at clinical high-risk for psychosis.
Mao Z; Tian L; Sun Y; Dong F; Wang C; Bo Q
BMC Psychiatry; 2023 Oct; 23(1):793. PubMed ID: 37907877
[TBL] [Abstract][Full Text] [Related]
36. Dynamic Interplay Between Insight and Persistent Negative Symptoms in First Episode of Psychosis: A Longitudinal Study.
Raucher-Chéné D; Bodnar M; Lavigne KM; Malla A; Joober R; Lepage M
Schizophr Bull; 2022 Jan; 48(1):211-219. PubMed ID: 34230974
[TBL] [Abstract][Full Text] [Related]
37. [Specialised first-episode psychosis services: a systematic review of the literature].
Skalli L; Nicole L
Encephale; 2011 May; 37 Suppl 1():S66-76. PubMed ID: 21600336
[TBL] [Abstract][Full Text] [Related]
38. The association between pre-morbid adjustment, duration of untreated psychosis and outcome in first-episode psychosis.
Jeppesen P; Petersen L; Thorup A; Abel MB; Øhlenschlaeger J; Christensen TØ; Krarup G; Jørgensen P; Nordentoft M
Psychol Med; 2008 Aug; 38(8):1157-66. PubMed ID: 18447961
[TBL] [Abstract][Full Text] [Related]
39. Duration of untreated psychosis as a predictor of outcome in first-episode schizophrenia: a retrospective study.
Altamura AC; Bassetti R; Sassella F; Salvadori D; Mundo E
Schizophr Res; 2001 Oct; 52(1-2):29-36. PubMed ID: 11595389
[TBL] [Abstract][Full Text] [Related]
40. Early intervention for psychosis.
Marshall M; Rathbone J
Cochrane Database Syst Rev; 2006 Oct; (4):CD004718. PubMed ID: 17054213
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
